Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives

Journal of Psychiatric Research

Volumn 34, Issue 4-5, 2000, Pages 355-364

  Flyckt, Lena ^a   Wiesel, Frits Axel ^b   Borg, Jörgen ^a   Edman, Gunnar ^a   Ansved, Tor ^c   Sydow, Olof ^a   Borg, Kristian ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrophy; Electromyography; Membrane; Muscle fibre; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; FAMILY HISTORY; FEMALE; FINGER; HISTOPATHOLOGY; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE BIOPSY; PRIORITY JOURNAL; SCHIZOPHRENIA; STATISTICAL ANALYSIS;

EID: 0033733042     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(00)00031-5     Document Type: Article

References (49)

1. Diagnostic and statistical manual of mental disorders
2. 'Cognitive dysmetria' as an integrative theory of schizophrenia; a dysfunction in cortical-subcortical-cerebellar circuitry?
3. Age-related changes in skeletal muscle cell
4. Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia
5. Muscle fiber types; how many and what kind?
6. Degeneration and regeneration of motor neurons in psychotic patients
7. Effects of exercise on the motor unit
8. Rapid examination of muscle tissue- an improved trichrome method for fresh-frosen sections
9. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls
10. Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia
11. Phosphorus magnetic resonance spectroscopy in schizophrenia; correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms
12. Changes in levels of phosphorus metabolites in temporal lobes of drug- naive schizophrenic patients
13. Increased serum phospholipase A2 activity in schizophrenia; a replication study
14. Backward masking performance as an indicator of vulnerability to schizophrenia
15. Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects
16. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia
17. The membrane hypothesis of schizophrenia
18. Schizophrenia as a membrane lipid disorder which is expressed throughout the body
19. Interrelationships between skeletal muscle adaptations and performance as studied by detraining and retraining
20. The Positive And Negative Syndrome Scale (PANSS) for schizophrenia
21. The genetics of schizophrenia; a current, genetic-epidemiologic perspective
22. Neurologic abnormalities in schizophrenic patients and their families II. Neurologic and psychiatric findings in relatives
23. Human aging, muscle mass, and fiber type composition
24. Validity of the family history method for identifying schizophrenia- related disorders
25. The effects of ageing, cachexia and neoplasms on striated muscle
26. Skeletal muscle pathology
27. Muscle abnormalities in psychotic patients II. Serum CPK activity, fiber abnormalities, and branching and sprouting of subterminal nerves
28. Neuromuscular abnormalities in the major mental illnesses II. Muscle fiber and subterminal motor nerve abnormalities
29. The specificity of the histochemical method of adenosine triphosphatase
30. Association of the Ban I dimorphic site at the human cytosolic phospholipase A2 gene with schizophrenia
31. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy [see comments]
32. Needle-technique for iterative muscle biopsy
33. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation
34. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2 (see comments)
35. Motor neuron branching patterns in psychotic patients
36. Validity of the familial and sporadic subtypes of schizophrenia
37. Neurological examination abnormalities in neuroleptic-naive patients with first break schizophrenia
38. Patterns of neuropsychological deficit in cases of schizophrenia spectrum disorder with and without a family history of psychosis
39. The cytochemical localization of oxidative enzymes
40. The Maudsley Family Study I: Structural brain changes on magnetic resonance imaging in familial schizophrenia
41. Brain changes in schizophrenia
42. Structured clinical interview for DSM III-R
43. Macro EMG
44. Single fibre electromyography
45. Macro EMG in healthy subjects of different ages
46. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy
47. Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to 1q25 by fluorescence in situ hybridization
48. The concept of target features in schizophrenia research
49. The genetics of schizophrenia. Current knowledge and future directions